Pharmacogenetics - Opportunities and challenges for health innovation

Publié par OECD, le 12 novembre 2009

132 pages

Résumé

Pharmacogenetics helps us understand the relationship between an individual's genetic make-up and the way medicines work for each person. This book reviews the use of pharmacogenetics across all stages of the health innovation cycle from research through to uptake by doctors and patients. It focuses on how to optimise the use of pharmacogenetics to deliver effective innovations for public health, and design policies that enhance their economic and social benefits. The book argues for large-scale studies to validate the biomarkers that underpin pharmacogenetics and policies to share the cost and risk of using pharmacogenetics to improve the use of existing  medicines. Governments and others need to align regulatory, reimbursement and other incentives and work with industry to measure better the impacts of pharmacogenetics. Health systems need to take positive steps to adapt to the use of pharmacogenetics and ensure that health professionals receive adequate training.

Relecture d'Aristoste

Gestion de la ressource et des ecosystemes ; thematique 1999

Geographical distribution of financial flows to developing countries 2011 - (bilingue ang/fr) disbur

Comprendre la gestion du personnel de l'entreprise: spécial dirigeants jeune entreprise (édition 2021)

Jean-François Porchez ; l'excellence dans la contrainte

Nouvelles acquisitions du Département des objets d'art, Musée du Louvre Tome 1 - 1980-1984

Hôtels et palaces de Nice ; une histoire du tourisme ; de 1780 à nos jours

ENCYCLOPEDIE BERBERE. - Tome 2

Critiques